How it should be taken
This medication is available in the form of tablets to take by mouth once a day, with or without food.
Dosage & When it is to be taken
Adjuvant treatment in early breast cancer; Advanced or locally advanced breast cancer in postmenopausal women: 1 mg/day.
When it is not to be taken (Contraindications)
Contraindicated in pregnant women, premenopausal women, patients who are experienced with hypersensitivity to any components.
Why it is prescribed (Indications)
This medication is a non-steroidal inhibitor used with other treatments, such as surgery or radiation, to treat early breast cancer in women who have experienced menopause. This medication is also used in women, who have experienced menopause, as a first treatment of breast cancer that has spread within the breast or to other areas of the body. It is also used to treat breast cancer in women whose breast cancer has worsened after taking tamoxifen (Nolvadex).
Category D :
There is positive evidence of human fetal risk based on adverse reaction data from investigational or marketing experience or studies in humans, but potential benefits may warrant use of the drug in pregnant women despite potential risks.
Warnings and Precautions
Caution should be exercised in patients with history of moderate or severe liver impairment, excess fat, children.
Be sure to mention any of the following: medications that contain estrogen such as hormone replacement therapy (HRT) and hormonal contraceptives (birth control pills, patches, rings, and injections); raloxifene (Evista); and tamoxifen (Nolvadex) before starting therapy with Anastrozole.
It may cause dizziness. Do not drive a car or operate machinery while driving this medication.
Avoid alcohol consumption.
Do the lab test for menopause if status is doubtful.
Bone mass density (bone mineral density) test should be conducted at the start of the therapy and at regular intervals thereafter.
Oral: Store at 20-25°C. Store it in airtight container.